Developer docs
API playgroundTry for free, no card

Search company profiles

AiScreenings

Full company profile

uuid000ac2h

Namestring
AiScreenings
Legal namestring
AiScreenings
Company typeenum
Private
Founded yearint
2017
Descriptiontext

AiScreenings is a French medical technology company founded in 2017 and headquartered in Paris that develops AI-powered medical devices for diagnostic support in dermatology and ophthalmology. The company's core product is the ALICIA platform, a medical-grade telemedicine technology hub that integrates three proprietary AI medical devices: aiSkin-DT for melanoma detection from skin lesion images, aiVista-SD for multiclass diabetic retinopathy screening, and aiVista-DT for combined diabetic retinopathy and glaucoma detection from fundus photographs. The technology is built on computer vision models trained for medical image analysis, with API-ready interoperability and confidential electronic medical record capabilities, and the ALICIA Pro mobile application is available on both Google Play and Apple App Store.

The company operates as a B2B medical technology provider targeting healthcare professionals and medical institutions, with a go-to-market built on enterprise sales and strategic partnerships. Key commercial relationships include a co-developed product (Olyatis) with Les Laboratoires Servier using aiVista-SD technology, a Microsoft partner relationship for cloud infrastructure, and an October 2024 tripartite partnership with Topcon Healthcare and BeeKeeperAI to validate the aiVista AI model on the Harmony platform for U.S. market entry. The company is ISO 13485 certified for medical device quality management and has received non-dilutive funding from the EU's Horizon 2020 research and innovation programme (grant agreement No 886575). Revenue figures are not publicly disclosed, and the company maintains a lean team of 11-50 employees.

Short descriptiontext

AiScreenings is a French medical technology company founded in 2017 that develops AI-powered medical devices for dermatology and ophthalmology diagnostics, serving healthcare professionals and institutions through its ALICIA telemedicine platform and proprietary aiSkin-DT, aiVista-SD, and aiVista-DT products.

Operating statusenum
Operating
Ownership categoryenum
Headcount rangeband
1–10
akta.pro rankint
HeadquartersParis, France
HQ citystring
Paris
HQ countrystring
France
HQ regionstring
Europe
Markets served

Serves global market

Offices1 record

Each record includes

City, Country, Type, Description, Source

Keyword5 values
AI medical imaging, dermatology diagnostics, ophthalmology screening, telemedicine platform, clinical decision support
Industry4 codes
PRIMARYHDAAAEAH
Medical Imaging AI
SECONDARYHLAAALAO
Digital & AI-Enabled Diagnostics (algorithmic interpretation, decision support tied to assays)
SECONDARYHDAEANAG
Responsible AI, Security & Privacy Platforms (Safety, Guardrails, PII)
Hardware, Technology & Telecom/Enterprise Platforms & Databases/Artificial Intelligence Platforms for Enterprise
SECONDARYHLACAFAO
Data Aggregation, Interoperability & APIs for RPM (FHIR/IoMT Gateways)
Healthcare & Life Sciences/Digital Health & Health IT/Remote Patient Monitoring (RPM) & Connected Care Platforms
NAICS code2 codes
  • Electromedical and Electrotherapeutic Apparatus Manufacturing334510
  • Navigational, Measuring, Electromedical, and Control Instruments Manufacturing33451
SIC code2 codes
  • Surgical & Medical Instruments & Apparatus3841
  • Electromedical & Electrotherapeutic Apparatus3845
Product category
AI Medical Imaging Diagnostics
GTM motion1 record

Each record includes

Type, Description, Source

Marketing channels3 records

Each record includes

Title, Type, Stage, Description, Source

Distribution channels3 records

Each record includes

Title, Type, Scope, Target buyer, Description, Source

Cost components5 values
Technology or R&D, Personnel, Operations, Marketing or Sales, Infrastructure
GTM typeB2B
B2B
Offering typeSoftware
Software
Brand1 of 5 records shown
1ALICIA®
Description

AI-Based Medical Devices Powered Telemedicine Solution - A medical grade technology hub enabling safe, fast and accurate diagnosis

aiscreenings.com
+4 more records
Core offering1 text field

AiScreenings develops and markets AI-powered medical devices for early diagnosis and treatment monitoring, focused on dermatology and ophthalmology. Its ALICIA® platform serves as a medical-grade technology hub that integrates three CE-marked AI medical devices—aiSkin-DT® (melanoma detection), aiVista-SD® (diabetic retinopathy), and aiVista-DT® (diabetic retinopathy and glaucoma)—to support healthcare professionals in medical image analysis, triaging, and telemedicine. The company also provides an API-ready collaborative platform enabling secure data exchange among doctors, specialists, and researchers.

Differentiator
Functional benefit
Problem solved
Quantifiable outcome1 value
  • Medical-grade technology hub enabling safe, fast and accurate diagnosis
Product overview1 text field

AiScreenings delivers a unified AI-powered medical technology platform centered on the ALICIA® telemedicine solution, which integrates multiple specialized medical devices for medical image analysis. The product portfolio includes three distinct AI medical devices: aiVista-SD® and aiVista-DT® for ophthalmology (diabetic retinopathy and glaucoma detection from fundus photographs), and aiSkin-DT® for dermatology (melanoma detection from skin lesion images). These devices share a common AI engine for computer vision analysis of medical images and are designed to interoperate through a collaborative platform enabling secure data sharing among doctors, specialists, and researchers.

Product and service4 records
1ALICIA®
CategoryTelemedicine Platform / Diagnostic Decision Support
Description

AI-based medical device powered telemedicine solution that serves as a smart companion supporting doctors in medical image diagnosis. Provides efficient, accurate, and reliable technology for early diagnosis and treatment monitoring across dermatology and ophthalmology; includes a collaborative platform for sharing among doctors, specialists, and researchers and an API-ready architecture for confidential data exchange.

2aiSkin-DT®
CategoryMedical Device (Dermatology Diagnostics)
Description

Melanoma detection medical device for dermatology that analyzes skin lesion images to support early detection of skin cancer. Designed for healthcare professionals requiring AI-powered diagnostic support for dermatological screening.

3aiVista-SD®
CategoryMedical Device (Ophthalmology Diagnostics)
Description

Multiclass diabetic retinopathy standalone medical device that enables early screening and detection of diabetic retinopathy from fundus photographs. Powers Olyatis™, a product developed in collaboration with Les Laboratoires Servier.

4aiVista-DT®
CategoryMedical Device (Ophthalmology Diagnostics)
Description

Multiclass diabetic retinopathy and glaucoma detection medical device that analyzes fundus photographs for multiple ocular pathologies, enabling comprehensive eye disease screening for healthcare professionals.

Scale indicator3 records

Each record includes

Type, Value, Description, Source

Partnership3 partners
Strategic tierCoreTypeTechnology or IntegrationAnnounced on2024-10-11
Description

Strategic partnership with BeeKeeperAI to use their EscrowAI privacy-preserving collaboration platform for validating AiScreenings' aiVista AI diagnostic algorithms. The collaboration utilizes confidential computing technology to protect algorithm intellectual property while enabling validation on real-world healthcare data.

Strategic tierCoreTypeStrategic or Co-development PartnerAnnounced on2024-10-11
Description

Strategic partnership combining Topcon's cloud-based clinical image management platform Harmony with BeeKeeperAI's EscrowAI. The initial project enables AiScreenings to validate its aiVista AI diagnostic model on fundus photographs hosted on the Harmony platform in the U.S. market.

Strategic tierCoreTypeTechnology or Integration
Description

AiScreenings is a Microsoft partner headquartered in France, utilizing Microsoft's cloud infrastructure and healthcare technology ecosystem for its AI medical device platform.

Recent move6 records

Each record includes

Date, Type, Title, Description, Source

Expansion highlight5 records

Each record includes

Type, Description

Peers10 records
TypeBroad incumbent
Description

AI-driven non-invasive cardiac diagnostics using imaging analysis. Comparable as an AI imaging diagnostics company with clinical workflow integration and reimbursement-driven adoption.

TypeEmerging player
Description

AI platform for ophthalmic data management and disease characterization. Closely overlaps AiScreenings' ophthalmology focus with an emphasis on fundus image analytics.

TypeDirect peer
Description

FDA-authorized AI-enabled spectroscopy device for skin cancer detection at the point of care. Competes with AiScreenings in dermatology AI screening.

TypeEmerging player
Description

AI-based pathology diagnostics company. Comparable as an adjacent medical-imaging AI vendor pursuing clinical-decision-support use cases in healthcare.

TypeBroad incumbent
Description

AI clinical workflow platform for stroke and other conditions; relevant adjacent peer operating in AI-enabled clinical decision support and imaging triage.

TypeDirect peer
Description

Medical imaging AI company with deep learning solutions for radiology and pathology; comparable as a multi-modality medical-imaging AI vendor targeting clinical decision support.

TypeDirect peer
Description

AI-powered dermatology app for skin cancer risk assessment from smartphone images. Direct competitor to AiScreenings' aiSkin-DT melanoma detection offering.

8Digital Diagnostics (IDx-DR)
TypeDirect peer
Description

Pioneer in autonomous AI for diabetic retinopathy detection (IDx-DR). Directly comparable to AiScreenings' aiVista-SD/DT ophthalmology offerings in target use case, regulatory pathway, and clinical buyer.

TypeDirect peer
Description

AI retinal screening for diabetic retinopathy and other ocular conditions, FDA-cleared. Closely overlaps AiScreenings' ophthalmology portfolio in product and clinical positioning.

10Zebra Medical Vision (Nanox)
TypeBroad incumbent
Description

AI radiology platform offering broad imaging diagnostics; represents a larger, broader-scope peer serving similar hospital customers with overlapping medical imaging AI capability.

Market position
Strengths5 records

Each record includes

Headline, Details, Source

Weaknesses5 records

Each record includes

Headline, Details, Source

Competitive moat5 records

Each record includes

Type, Details

Key risks5 records

Each record includes

Headline, Details, Source

Key highlights7 records

Each record includes

Headline, Details, Source

Customer concentration

Classification, Details

Named customers2 records

Each record includes

Name, Industry, Type, Use case, Source, UUID

Segment3 records

Each record includes

Title, Type, Primary, Description, Pain point addressed, Use case, Source

Ideal customer profile2 records

Each record includes

Profile, Firmographic size, Sales motion, Sales cycle length, Buying structure, Purchase trigger, Buyer persona, Geography, Industry vertical, Primary use case, Description, Pain points, Evidence proof points, Target buyer

Technology focused
Yes
API detail
Has APIbool
Yes

Docs URL, Description

AI capability3 records

Each record includes

Type, Description, Source

AI maturity
App detail

Has app

Feature4 records

Each record includes

Title, Differentiator, Description, Source

Core technology
Revenue estimate
Valuation estimate
Number of profiles
Profiles2 records

Each record includes

Name, Designation, Designation category, Overview, Profile commentary, Source

No data
Compliance1 record

Each record includes

Name, Class, Description

Funding overview

Funding stage, Last funding date, Total funding USD

Funding rounds

Each record includes

Round, Amount USD, Date, Pre money valuation, Total investors, Investors, News

Investors

Each record includes

Name, Type, Date of entry, Rounds participated, Website

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

M&A

Each record includes

Name, Acquisition type, Announced date, Completed date, Status, Website, News

Investment

Each record includes

Name, Round, Announced date, Lead investor, Website, News

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

AiScreenings

AI Medical Imaging Diagnosticsaiscreenings.com

AiScreenings is a French medical technology company founded in 2017 that develops AI-powered medical devices for dermatology and ophthalmology diagnostics, serving healthcare professionals and institutions through its ALICIA telemedicine platform and proprietary aiSkin-DT, aiVista-SD, and aiVista-DT products.

What AiScreenings does

AiScreenings is a French medical technology company founded in 2017 and headquartered in Paris that develops AI-powered medical devices for diagnostic support in dermatology and ophthalmology. The company's core product is the ALICIA platform, a medical-grade telemedicine technology hub that integrates three proprietary AI medical devices: aiSkin-DT for melanoma detection from skin lesion images, aiVista-SD for multiclass diabetic retinopathy screening, and aiVista-DT for combined diabetic retinopathy and glaucoma detection from fundus photographs. The technology is built on computer vision models trained for medical image analysis, with API-ready interoperability and confidential electronic medical record capabilities, and the ALICIA Pro mobile application is available on both Google Play and Apple App Store.

The company operates as a B2B medical technology provider targeting healthcare professionals and medical institutions, with a go-to-market built on enterprise sales and strategic partnerships. Key commercial relationships include a co-developed product (Olyatis) with Les Laboratoires Servier using aiVista-SD technology, a Microsoft partner relationship for cloud infrastructure, and an October 2024 tripartite partnership with Topcon Healthcare and BeeKeeperAI to validate the aiVista AI model on the Harmony platform for U.S. market entry. The company is ISO 13485 certified for medical device quality management and has received non-dilutive funding from the EU's Horizon 2020 research and innovation programme (grant agreement No 886575). Revenue figures are not publicly disclosed, and the company maintains a lean team of 11-50 employees.

AiScreenings firmographics

Firmographics
Name
AiScreenings
Legal name
AiScreenings
Website
https://aiscreenings.com
Company type
Private
Founded year
2017
Operating status
Operating
Headcount range
1–10 employees
Short description
AiScreenings is a French medical technology company founded in 2017 that develops AI-powered medical devices for dermatology and ophthalmology diagnostics, serving healthcare professionals and institutions through its ALICIA telemedicine platform and proprietary aiSkin-DT, aiVista-SD, and aiVista-DT products.
Ownership category
akta.pro rank

AiScreenings industry classification

Industry
Product category
AI Medical Imaging Diagnostics
NAICS
Electromedical and Electrotherapeutic Apparatus Manufacturing (334510), Navigational, Measuring, Electromedical, and Control Instruments Manufacturing (33451)
SIC
Surgical & Medical Instruments & Apparatus (3841), Electromedical & Electrotherapeutic Apparatus (3845)
akta.pro industry
PRIMARYHDAAAEAH
Medical Imaging AI
SECONDARYHLAAALAO
Digital & AI-Enabled Diagnostics (algorithmic interpretation, decision support tied to assays)
SECONDARYHDAEANAG
Responsible AI, Security & Privacy Platforms (Safety, Guardrails, PII)
Hardware, Technology & Telecom/Enterprise Platforms & Databases/Artificial Intelligence Platforms for Enterprise
SECONDARYHLACAFAO
Data Aggregation, Interoperability & APIs for RPM (FHIR/IoMT Gateways)
Healthcare & Life Sciences/Digital Health & Health IT/Remote Patient Monitoring (RPM) & Connected Care Platforms

Keywords

  • AI medical imaging
  • Dermatology diagnostics
  • Ophthalmology screening
  • Telemedicine platform
  • Clinical decision support

Where AiScreenings is headquartered

Location

Headquarters

HQ city
Paris
HQ country
France
HQ region
Europe

Offices1 record

Markets served

AiScreenings business model

Business model
GTM type
B2B
Offering type
Software
Cost components
Technology or R&D, Personnel, Operations, Marketing or Sales, Infrastructure

Go-to-market motion1 record

Distribution channels3 records

Marketing channels3 records

AiScreenings product offering

Product offering

Core offering

AiScreenings develops and markets AI-powered medical devices for early diagnosis and treatment monitoring, focused on dermatology and ophthalmology. Its ALICIA® platform serves as a medical-grade technology hub that integrates three CE-marked AI medical devices—aiSkin-DT® (melanoma detection), aiVista-SD® (diabetic retinopathy), and aiVista-DT® (diabetic retinopathy and glaucoma)—to support healthcare professionals in medical image analysis, triaging, and telemedicine. The company also provides an API-ready collaborative platform enabling secure data exchange among doctors, specialists, and researchers.

Product overview

AiScreenings delivers a unified AI-powered medical technology platform centered on the ALICIA® telemedicine solution, which integrates multiple specialized medical devices for medical image analysis. The product portfolio includes three distinct AI medical devices: aiVista-SD® and aiVista-DT® for ophthalmology (diabetic retinopathy and glaucoma detection from fundus photographs), and aiSkin-DT® for dermatology (melanoma detection from skin lesion images). These devices share a common AI engine for computer vision analysis of medical images and are designed to interoperate through a collaborative platform enabling secure data sharing among doctors, specialists, and researchers.

Differentiator

Problem solved

Functional benefit

Brands

  • ALICIA®: AI-Based Medical Devices Powered Telemedicine Solution - A medical grade technology hub enabling safe, fast and accurate diagnosis
  • aiSkin-DT®
  • aiVista-SD®
  • aiVista-DT®
  • ALICIA Pro

Products and services

  • ALICIA® AI-based medical device powered telemedicine solution that serves as a smart companion supporting doctors in medical image diagnosis. Provides efficient, accurate, and reliable technology for early diagnosis and treatment monitoring across dermatology and ophthalmology; includes a collaborative platform for sharing among doctors, specialists, and researchers and an API-ready architecture for confidential data exchange.
  • aiSkin-DT® Melanoma detection medical device for dermatology that analyzes skin lesion images to support early detection of skin cancer. Designed for healthcare professionals requiring AI-powered diagnostic support for dermatological screening.
  • aiVista-SD® Multiclass diabetic retinopathy standalone medical device that enables early screening and detection of diabetic retinopathy from fundus photographs. Powers Olyatis™, a product developed in collaboration with Les Laboratoires Servier.
  • aiVista-DT® Multiclass diabetic retinopathy and glaucoma detection medical device that analyzes fundus photographs for multiple ocular pathologies, enabling comprehensive eye disease screening for healthcare professionals.

Quantifiable outcome

  • Medical-grade technology hub enabling safe, fast and accurate diagnosis

Companies that use AiScreenings

Customer profile

Named customers2 records

Segments3 records

Ideal customer profiles2 records

AiScreenings technology and API

Technology

Technology focussed Yes

API detail

Has API
Yes
API docs
API detail

Core technology

AI maturity

App detail

AI capability3 records

Feature4 records

AiScreenings partnerships and signals

Strategic signal

Partnerships

Three partnerships are on record, tiered core.

  • BeeKeeperAIcoreTechnology or Integration · 11 October 2024Strategic partnership with BeeKeeperAI to use their EscrowAI privacy-preserving collaboration platform for validating AiScreenings' aiVista AI diagnostic algorithms. The collaboration utilizes confidential computing technology to protect algorithm intellectual property while enabling validation on real-world healthcare data.
  • Topcon HealthcarecoreStrategic or Co-development Partner · 11 October 2024Strategic partnership combining Topcon's cloud-based clinical image management platform Harmony with BeeKeeperAI's EscrowAI. The initial project enables AiScreenings to validate its aiVista AI diagnostic model on fundus photographs hosted on the Harmony platform in the U.S. market.
  • MicrosoftcoreTechnology or IntegrationAiScreenings is a Microsoft partner headquartered in France, utilizing Microsoft's cloud infrastructure and healthcare technology ecosystem for its AI medical device platform.

Scale indicators3 records

Recent moves6 records

Expansion highlights5 records

AiScreenings competitors and assessment

Company assessment

Broad incumbents

  • HeartFlow: AI-driven non-invasive cardiac diagnostics using imaging analysis. Comparable as an AI imaging diagnostics company with clinical workflow integration and reimbursement-driven adoption.
  • Viz.ai: AI clinical workflow platform for stroke and other conditions; relevant adjacent peer operating in AI-enabled clinical decision support and imaging triage.
  • Zebra Medical Vision (Nanox): AI radiology platform offering broad imaging diagnostics; represents a larger, broader-scope peer serving similar hospital customers with overlapping medical imaging AI capability.

Emerging players

  • RetinAI Discovery (Ikerian AG): AI platform for ophthalmic data management and disease characterization. Closely overlaps AiScreenings' ophthalmology focus with an emphasis on fundus image analytics.
  • Paige.AI: AI-based pathology diagnostics company. Comparable as an adjacent medical-imaging AI vendor pursuing clinical-decision-support use cases in healthcare.

Direct peers

  • DermaSensor: FDA-authorized AI-enabled spectroscopy device for skin cancer detection at the point of care. Competes with AiScreenings in dermatology AI screening.
  • Lunit: Medical imaging AI company with deep learning solutions for radiology and pathology; comparable as a multi-modality medical-imaging AI vendor targeting clinical decision support.
  • SkinVision: AI-powered dermatology app for skin cancer risk assessment from smartphone images. Direct competitor to AiScreenings' aiSkin-DT melanoma detection offering.
  • Digital Diagnostics (IDx-DR): Pioneer in autonomous AI for diabetic retinopathy detection (IDx-DR). Directly comparable to AiScreenings' aiVista-SD/DT ophthalmology offerings in target use case, regulatory pathway, and clinical buyer.
  • AEYE Health: AI retinal screening for diabetic retinopathy and other ocular conditions, FDA-cleared. Closely overlaps AiScreenings' ophthalmology portfolio in product and clinical positioning.

Market position

Strengths5 records

Weaknesses5 records

Competitive moat5 records

Key risks5 records

Key highlights7 records

Customer concentration

AiScreenings social profiles

Digital presence

AiScreenings compliance and trust

Trust signal

Compliance1 record

AiScreenings financial estimates

Financial estimate

Revenue estimate

Valuation estimate

AiScreenings leadership team

Management profile

Number of profiles

Profiles2 records

AiScreenings funding detail

Funding detail

Funding overview

Funding rounds

Investors

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

AiScreenings M&A and investment

M&A and investment

M&A

Investments

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Frequently asked questions about AiScreenings

What does AiScreenings do?

AiScreenings develops and markets AI-powered medical devices for early diagnosis and treatment monitoring, focused on dermatology and ophthalmology. Its ALICIA® platform serves as a medical-grade technology hub that integrates three CE-marked AI medical devices—aiSkin-DT® (melanoma detection), aiVista-SD® (diabetic retinopathy), and aiVista-DT® (diabetic retinopathy and glaucoma)—to support healthcare professionals in medical image analysis, triaging, and telemedicine. The company also provides an API-ready collaborative platform enabling secure data exchange among doctors, specialists, and researchers.

Is AiScreenings a public or private company?

AiScreenings is a private company. It is classified as unknown and is currently operating.

When was AiScreenings founded?

AiScreenings was founded in 2017. It employs 1 to 10 people.

Where is AiScreenings based?

AiScreenings is headquartered in Paris, France, in the Europe region.

Who are AiScreenings's main competitors?

Broad incumbents on record are HeartFlow, Viz.ai and Zebra Medical Vision (Nanox). Emerging players are RetinAI Discovery (Ikerian AG) and Paige.AI. Direct peers are DermaSensor, Lunit, SkinVision, Digital Diagnostics (IDx-DR) and AEYE Health.

Does AiScreenings have an API?

Yes. AiScreenings provides API-ready interoperability enabling confidential data exchange in healthcare settings. The platform supports confidential interoperability capabilities for secure integration with existing healthcare systems.

What industry is AiScreenings in?

AiScreenings's product category is AI Medical Imaging Diagnostics. Its primary akta.pro industry code is HDAAAEAH, Medical Imaging AI, with a secondary code of HLAAALAO, Digital & AI-Enabled Diagnostics (algorithmic interpretation, decision support tied to assays). Its NAICS code is 334510 and its SIC code is 3841.

Unlock the full company data

50 free credits on sign-up, no credit card required.

Contact sales
Live signals